The AI revolution has become a mainstream topic, driven by user-friendly generative AI applications such as OpenAI’s ChatGPT. However, while these tools raise legal and ethical concerns, the emergence of powerful large language models (LLMs) also has the potential to revolutionize healthcare.
The U.K. Government announced today that it is investing £21 million ($26.75 million) in National Health Service (NHS) trusts to accelerate the deployment of promising AI tools in hospitals across the country.
It’s important to note that the NHS has faced controversy in the past regarding its AI initiatives. However, with recent advancements in AI and LLMs, the U.K. has positioned itself at the forefront of the AI industry, organizing global summits, offering million-pound prizes, and providing funding for AI development.
The U.K. has now launched the AI Diagnostic Fund to bring AI imaging and decision-support tools for diagnosing and treating heart conditions, cancer, and strokes. The goal is to deploy AI tools across all NHS stroke networks by the end of the year and use AI to analyze chest x-rays for early detection of lung cancer.
NHS Trusts will be able to apply for funding for any AI diagnostic tool they deem suitable, with a focus on value-for-money justification.
